Biological Treatment
Therapy Change from Adalimumab to Baricitinib in Patients with Rheumatoid Arthritis
The aim of the presented analysis of data from the RA-BEAM study was to evaluate the clinical…
Persistence of Treatment with Secukinumab and Ixekizumab in Patients with Moderate to Severe Psoriasis
Although IL-17 targeted drugs are increasingly used in the treatment of moderate to severe…
Pain Relief and Functional Score Improvement in Patients with Low Rheumatoid Arthritis Activity: Baricitinib vs. Adalimumab
In patients with rheumatoid arthritis, pain and functional impairment may persist even with…
Efficacy and Speed of Pain Relief in Rheumatoid Arthritis When Adding Baricitinib to Methotrexate
The phase III clinical trial RA-BEAM conducted in patients with rheumatoid arthritis (RA)…
1
2
Subscribe
Conferences news
Go to records
Most read on this topic
Journal on this topic
Related topic
Interesting links
Conferences news
Go to records
Most read on this topic
- Alopecia Areata – Autoimmune Inflammatory Disease and a New Targeted Treatment Option
- How do IL-17 and IL-23 inhibitors fare in the treatment of psoriasis in direct comparison?
- Experiences with Long-term Treatment of Psoriasis with Interleukin 17A Inhibitor
- New Therapeutic Options in Light of Current Knowledge on the Pathogenesis of Atopic Dermatitis
- Improvement of Joint and Skin Symptoms and Their Contribution to Improving the Quality of Life in Patients with Psoriatic Arthritis
- Biological treatment of psoriatic arthritis in the 1st line – results of the SPIRIT-H2H study after 1 year of follow-up
Journal on this topic
Related topic
Interesting links